A Study of PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3
Clinical trial NCT01258101 · COMPLETED
Trial details
- NCT number
- NCT01258101
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2008-07-01
- Enrollment
- 395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.